PersonAuto-indexed · Unverified
Michel Revel
Kloten, SWITZERLAND· Director, Executive Officer
Named on 4 public capital-raising filings across 1 company. Compiled automatically from public SEC filings — not verified by this individual.
Companies
Filings (4)
NewcelX Ltd. raised $2.9M
NLS Pharmaceutics Ltd.· Director· Aug 24, 2026
NewcelX Ltd. raised $2.9M
NLS Pharmaceutics Ltd.· Executive Officer· Aug 24, 2026
NewcelX Ltd. raised $3.4M
NLS Pharmaceutics Ltd.· Director· May 13, 2026
NewcelX Ltd. raised $3.4M
NLS Pharmaceutics Ltd.· Executive Officer· May 13, 2026
